Alignment Healthcare, Inc. (ALHC) Q2 2026 Earnings Call Transcript
Alignment Healthcare Inc ALHC
$14.85
โผ -20.20%
($-3.76)
⬇️ Below Yest. Low
Open
$15.50
Prev Close
$18.61
Day Range
$13.14 โ $16.49
52W Range
$12.01 โ $25.12
Market Cap
$3.07B
P/E (TTM)
194.25
Beta
1.14
EPS (TTM)
$0.09
๐ Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-03-26 |
| Shares Out. | 206,730,000 |
| Website | alignmenthealth.com/ โ |
| Phone | 18443102247 |
| Employees | 1,849 |
| Revenue | $1.23B |
| Gross Profit | $135.8M |
| Net Income | $11.4M |
| Free Cash Flow | $226.1M |
| Total Assets | $1.26B |
| Total Liabilities | $1.05B |
| Equity | $206.9M |
About Alignment Healthcare Inc
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Alignment Healthcare Inc is a publicly traded company under the ticker symbol ALHC on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
20 analysts (2026-07-01)
๐ฐ Latest News for ALHC
Thursday's after hours session: top gainers and losers
Alignment Healthcare (NASDAQ:ALHC) Beats Q2 Earnings but Guidance Miss Sends Shares Tumbling
12 Health Care Stocks Moving In Thursday's After-Market Session
Alignment Healthcare Raises FY2026 Sales Guidance from $5.160B-$5.205B to $5.195B-$5.225B vs $5.189B Est
Alignment Healthcare Sees Q3 Sales $1.300B-$1.320B vs $1.315B Est
Alignment Healthcare Q2 EPS $0.17 Beats $0.13 Estimate, Sales $1.336B Beat $1.310B Estimate
Alignment Healthcare (ALHC) Stock Looks Reasonable On Its 238% Three Year Run

